Order Hyalgan® for Clinics

Hyalgan® is a sterile sodium hyaluronate solution supplied in a single-use prefilled syringe for intra-articular injection into the knee. Orthopedic practices, sports medicine clinics, pain centers and hospital departments can order Hyalgan wholesale for in-office viscosupplementation series. FDA labeling describes its use for pain in osteoarthritis of the knee in patients who have not responded adequately to conservative nonpharmacologic therapy and simple analgesics such as acetaminophen.

How sodium hyaluronate works and where Hyalgan fits in practice

Hyaluronan is a normal part of synovial fluid and gives it viscosity and elasticity. In osteoarthritis, both the concentration and the molecular weight of joint hyaluronan fall, so the fluid cushions and lubricates less well. Viscosupplementation aims to restore some of that viscoelastic behavior with an injected hyaluronate solution. The labeling for Hyalgan notes that the precise mechanism of action in the osteoarthritic knee has not been established.

In practice, the product sits after first-line care rather than alongside it. Most clinics reserve it for patients who have already tried activity modification, physical therapy, weight management and simple analgesics without adequate relief, and who want to delay or avoid a more invasive step. Per FDA labeling, the treatment course is five injections given one week apart, and the labeling notes that some patients may experience benefit after three injections.

Why it matters: The course length, not the single syringe, drives how much product a clinic needs on the shelf.

Syringe format, course planning and professional-use ordering

FDA labeling describes Hyalgan as a 2 mL prefilled syringe containing 20 mg of sodium hyaluronate, intended for a single intra-articular injection. The syringe is single use. Do not divide one syringe between patients or between knees, and do not retain partially used syringes for a later visit.

Practices that order Hyalgan wholesale usually plan inventory by the number of injection courses they expect, not by individual units. A five-injection course treats one knee, so bilateral treatment for the same patient doubles the requirement. Build a small buffer for rescheduled visits, keep the quantity matched to your booked injection clinics, and rotate stock so the shortest-dated syringes are used first. Choose the quantity shown with the item that matches your planned course volume.

Ordering is restricted to professional users. FDA labeling restricts sale of the device to use by or on the order of a physician, so clinic credentials and professional-use documentation may be requested with an account. Med Wholesale Supplies is a wholesale supplier of aesthetic, orthopedic and medical products to clinics, hospitals and medical professionals, operating since 2013.

Regulatory status and the question of a Hyalgan generic

Hyalgan is regulated in the United States as a Class III medical device cleared through premarket approval, not as a small-molecule drug. Because of that, there is no FDA generic-equivalence rating, no Orange Book listing and no therapeutically equivalent generic version to substitute. Other intra-articular hyaluronic acid products are approved under their own applications and are not automatically interchangeable with this one.

Use in joints other than the knee, including the hip, shoulder or small joints, is outside the approved indication. Any such use is off-label, should be documented as a clinician-led decision, and is not promoted here. The same applies to dosing schedules that differ from the labeled five-week course.

Patient selection, contraindications and precautions

Screening before the first injection prevents most avoidable problems. The labeling and instructions for use describe the following limits and cautions:

• Do not use in patients with known hypersensitivity to hyaluronate preparations.
• Use caution in patients who are allergic to avian proteins, feathers or egg products, since the hyaluronate is extracted from rooster combs.
• Do not inject into a knee with an active joint infection, or through skin that is infected or shows active disease at the injection site.
• Remove any joint effusion before injecting, so the product is not diluted in excess fluid.
• Safety and effectiveness have not been established in pregnancy, in nursing mothers or in children.
• The product is for intra-articular use only. Avoid intravascular injection.

One practical skin-prep point is easy to miss: the instructions for use advise against disinfectants containing quaternary ammonium salts, because hyaluronan can precipitate in their presence. Confirm that the antiseptic on your injection tray is compatible before the procedure starts.

Counsel patients to avoid strenuous or prolonged weight-bearing activity in the first 48 hours after each injection. Labeling gives examples such as jogging, tennis and standing for more than an hour at a time.

Side effects, warnings and monitoring

The most common reactions reported with intra-articular hyaluronate are local. These include transient pain, warmth, swelling or stiffness in the injected knee, injection-site reaction and arthralgia. Symptoms are usually short-lived; labeling suggests ice application and rest for the affected joint. Rash, pruritus and systemic hypersensitivity reactions have been reported less often.

Observe the patient briefly after each injection, particularly the first, and record any reaction in the chart. Advise patients to contact the clinic promptly if joint pain, swelling, redness or fever increases over the days after an injection, because septic arthritis and acute inflammatory flare need urgent assessment rather than another dose. Reassess response at the end of the course before planning any repeat series, and avoid stacking it with other intra-articular injections in the same visit unless a clinician has specifically decided otherwise.

No specific drug interactions are listed for intra-articular sodium hyaluronate, but patients on anticoagulants warrant the usual care around joint puncture. Keep an anaphylaxis kit available in the treatment room, as with any injectable product.

Receiving, handling and documentation in the clinic

Treat each delivery as a short, repeatable check. Beyond confirming the storage condition shown with the item, your team should:

• Match the carton quantity and product description against the order before putting stock away.
• Record lot numbers and expiry dates on receipt, and log them again in the patient chart at each injection.
• Inspect the syringe and packaging for damage, a broken seal or a compromised blister before opening.
• Check the solution visually; it should be clear and free of particulates. Discard any unit that looks abnormal.
• Keep the product in its original packaging until the sterile field is prepared.
• Dispose of the used syringe and needle in a sharps container immediately after the injection.

Aseptic technique applies from the moment the tray is set. The syringe is supplied ready to inject, so no reconstitution or dilution step is involved, which shortens room time but leaves no margin for a contaminated field. Standardize the needle gauge and approach your injectors prefer, and keep that supply stocked alongside the product so courses are not interrupted.

Quick tip: Note the planned injection dates for each course in your booking system so stock arrives ahead of week one.

How it compares with other intra-articular hyaluronic acid products

Viscosupplements differ in ways that matter to scheduling and to patient conversations, without any one being ranked above another here:

• Source: some are avian-derived, like this one, while others are produced by bacterial fermentation. That difference drives the avian-allergy caution.
• Molecular weight: products range from lower-molecular-weight solutions to cross-linked, higher-molecular-weight gels.
• Course length: labeled regimens vary from a single injection to three or five weekly injections, which changes visit count and chair time.
• Regulatory file: each product carries its own premarket approval, so clinical data and approved indications are specific to that brand.

For clinics that run a mixed injection list, stocking one five-injection product and one shorter-course product can cover both patients who are comfortable with weekly visits and those who are not. Selection remains a clinical decision based on allergy history, prior response and the patient’s ability to attend.

Clinic workflow questions that come up most

Teams new to viscosupplementation usually ask three practical things. First, who injects: the procedure requires a clinician trained in intra-articular injection of the knee, including effusion aspiration when needed. Second, how the course is tracked: a simple course sheet with dates, lot numbers, injected side and any reaction keeps the five visits auditable. Third, what happens if a patient misses week three: the clinician decides whether to continue the series or restart, and that decision should be documented rather than handled informally at reception.

Product facts above are drawn from the FDA labeling and the manufacturer’s instructions for use for Hyalgan. Review the current instructions for use supplied with the product before the first injection in your clinic, and keep a copy accessible in the treatment room.

This content is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified clinician or pharmacist about your situation, and seek urgent care or call your local emergency number for severe or worsening symptoms.